<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
71863-123-14
</NDCCode>
<PackageDescription>
145 mL in 1 BOTTLE (71863-123-14)
</PackageDescription>
<NDC11Code>
71863-0123-14
</NDC11Code>
<ProductNDC>
71863-123
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Desmoda
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Desmopressin Acetate Oral Solution
</NonProprietaryName>
<DosageFormName>
SOLUTION
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20260302
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
NDA219873
</ApplicationNumber>
<LabelerName>
Eton Pharmaceuticals, Inc.
</LabelerName>
<SubstanceName>
DESMOPRESSIN ACETATE
</SubstanceName>
<StrengthNumber>
.05
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes>
Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-03-04
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20260302
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>